Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Germ Cell Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05400603
What this trial is testing

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Who this might be right for
NeuroblastomaRefractory NeuroblastomaRelapsed Neuroblastoma+2 more
Emory University 24
Testing effectiveness (Phase 2)Study completedNCT01349660
What this trial is testing

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
SCRI Development Innovations, LLC 88
Very early researchActive Not RecruitingNCT06148636
What this trial is testing

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor of the LungNeuroendocrine Tumor Grade 1+2 more
David Bushnell 24
Testing effectiveness (Phase 2)Ended earlyNCT00042952
What this trial is testing

Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

Who this might be right for
Ovarian DysgerminomaRecurrent Malignant Testicular Germ Cell TumorRecurrent Ovarian Germ Cell Tumor+5 more
National Cancer Institute (NCI) 32
Early research (Phase 1)Ended earlyNCT05130255
What this trial is testing

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Who this might be right for
SCLCMalignant MelanomaSarcoma+1 more
Y-mAbs Therapeutics 23
Testing effectiveness (Phase 2)Study completedNCT01114555
What this trial is testing

Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT02478164
What this trial is testing

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 17
Testing effectiveness (Phase 2)Study completedNCT02581930
What this trial is testing

Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

Who this might be right for
Metastatic MelanomaRecurrent Cutaneous MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT02780804
What this trial is testing

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Brain Stem NeoplasmPineal Region NeoplasmRecurrent Lymphoma+7 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00407433
What this trial is testing

Clinical Studies of Gemcitabine-Oxaliplatin

Who this might be right for
MedulloblastomaCentral Nervous System TumorsNeuroblastoma+1 more
Gustave Roussy, Cancer Campus, Grand Paris 156
Testing effectiveness (Phase 2)Study completedNCT02300987
What this trial is testing

A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

Who this might be right for
Teratoma
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT01767194
What this trial is testing

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Who this might be right for
GanglioneuroblastomaRecurrent Neuroblastoma
National Cancer Institute (NCI) 73
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT00112645
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
NeuroblastomaSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Milton S. Hershey Medical Center 10
Early research (Phase 1)Study completedNCT03389802
What this trial is testing

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

Who this might be right for
Glioblastoma MultiformeHigh-grade Astrocytoma Not Otherwise Specified (NOS)CNS Primary Tumor, Not Otherwise Specified (NOS)+3 more
Pediatric Brain Tumor Consortium 32
Testing effectiveness (Phase 2)WithdrawnNCT02521090
What this trial is testing

EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma

Who this might be right for
Adult Brain GlioblastomaAdult GliosarcomaRecurrent Brain Neoplasm
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Looking for participantsNCT07306559
What this trial is testing

Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Who this might be right for
Advanced Relapsed or Refractory Germ Cell TumoursAdvanced Relapsed or Refractory Endometrial CancerAdvanced Relapsed or Refractory Ovarian Cancer
Boehringer Ingelheim 187
Early research (Phase 1)Active Not RecruitingNCT01364051
What this trial is testing

Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies

Who this might be right for
Metastatic MelanomaRefractory Malignant Solid NeoplasmStage IV Cutaneous Melanoma AJCC v6 and v7+1 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Next Page